ViroGates A/S
CSE:VIRO
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
ViroGates A/S
CSE:VIRO
|
DK |
|
G
|
Geox SpA
XMUN:GHH
|
IT |
Intrinsic Value
The intrinsic value of ViroGates A/S (VIRO) under the Base Case is 4.85 DKK per share.
Compared with the current market price of 8.4 DKK, the stock appears
Overvalued by 42% .
The intrinsic value is calculated using valuation multiples.
Do our valuations actually work? See backtest results .
Cheap or expensive for this stock?
This block shows whether today’s valuation is cheap or expensive compared with the stock’s own history, and what happened after similar valuations in the past.
We compare the gap between the stock’s price and our estimated value over time.
- Undervalued can still be historically expensive. The stock may trade below our estimated value, but usually offer an even bigger discount.
- Overvalued can still be historically cheap. The stock may trade above our estimated value, but usually carry an even higher premium.
Market expectations can differ from our model, which may not fully capture everything affecting the price. That is why some stocks regularly trade above our estimated value and others below it.
The scale and chart show how today’s valuation compares with the past. The cards summarize past returns and waiting times until the stock stopped being cheap or expensive. This can happen because the price changed, our estimated value changed, or both.
Only completed periods are included. These are past results, not forecasts. The usual historical range does not necessarily mean fair value.
Fundamental Analysis
What ViroGates A/S Does
ViroGates A/S is a Danish medical diagnostics company that sells tests for measuring the suPAR biomarker in blood. Its main product family, suPARnostic, is used to help doctors assess a patient’s risk of serious illness and to support decisions about treatment and hospital care. The company does not make broad healthcare devices; it focuses on this one biomarker-based testing niche.
- Headquarters
- Denmark DK
- Employees
- 28
- IPO date
- Jun 26, 2018
Revenue & Expenses Breakdown
ViroGates A/S
Earnings Waterfall
ViroGates A/S
The intrinsic value for ViroGates A/S (VIRO) under the Base Case is 4.85 DKK.
Compared with the current market price of 8.4 DKK, the stock appears Overvalued by 42% .